Home
Online Library
Uptodate
Journal
Educational Video
Buy A Package
Uptodate
Journal
Main Language Online Library
Persian Online Library
Educational Video
Office And Clinic Software
Turn Ratings
About Us
Contact Us
Login
Register
Searching For Content
Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining: 4 Item
Version October 2024
Search
Anticoagulation therapy for venous thromboembolism (lower extremity venous thrombosis and pulmonary embolism) in adult patients with malignancy
COVID-19: Hypercoagulability
COVID-19: Vaccine-induced immune thrombotic thrombocytopenia (VITT)
Cancer-associated hypercoagulable state: Causes and mechanisms
Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria
Clinical manifestations of antiphospholipid syndrome
Diagnosis of antiphospholipid syndrome
Hypercoagulability in nephrotic syndrome
Management of antiphospholipid syndrome
Multiple myeloma: Prevention of venous thromboembolism
Overview of homocysteine
Pathogenesis of antiphospholipid syndrome
Primary (spontaneous) upper extremity deep vein thrombosis
Renal vein thrombosis in adults
Risk and prevention of venous thromboembolism in adults with cancer
Treatment and prognosis of paroxysmal nocturnal hemoglobinuria
Acute coronary syndrome: Oral anticoagulation in medically treated patients
Anticoagulant and antiplatelet therapy in patients with an unruptured intracranial aneurysm
Anticoagulation in individuals with thrombocytopenia
Antithrombotic therapy in patients with infective endocarditis
Biology of warfarin and modulators of INR control
Clinical presentation and diagnosis of heparin-induced thrombocytopenia
Clinical use of coagulation tests
Direct oral anticoagulants (DOACs) and parenteral direct-acting anticoagulants: Dosing and adverse effects
Fondaparinux: Dosing and adverse effects
Heparin and LMW heparin: Dosing and adverse effects
Investigational anticoagulants
Management of bleeding in patients receiving direct oral anticoagulants
Management of heparin-induced thrombocytopenia
Management of heparin-induced thrombocytopenia (HIT) during cardiac or vascular surgery
Management of warfarin-associated bleeding or supratherapeutic INR
Perioperative management of patients receiving anticoagulants
Prevention of venous thromboembolism (VTE) in adults with non-major extremity orthopedic injury with or without surgical repair
Prevention of venous thromboembolism in adults undergoing hip fracture repair or hip or knee replacement
Reversal of anticoagulation in intracranial hemorrhage
Risks and prevention of bleeding with oral anticoagulants
Treatment and prevention of venous thromboembolism in patients with brain tumors
Use of anticoagulants during pregnancy and postpartum
Warfarin and other VKAs: Dosing and adverse effects
Antiphospholipid syndrome: Obstetric implications and management in pregnancy
Catastrophic antiphospholipid syndrome (CAPS)
Clinical manifestations of antiphospholipid syndrome
Diagnosis of antiphospholipid syndrome
HIV-associated cytopenias
Management of antiphospholipid syndrome
Pathogenesis of antiphospholipid syndrome
Acquired hemophilia A (and other acquired coagulation factor inhibitors)
Approach to the adult with a suspected bleeding disorder
Approach to the adult with epistaxis
Bleeding disorder of unknown cause (BDUC)
COVID-19: Hypercoagulability
Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)
Diagnostic approach to thrombocytopenia in adults
Disorders of fibrinogen
Evaluation and management of disseminated intravascular coagulation (DIC) in adults
Hemostatic abnormalities in patients with liver disease
Hereditary hemorrhagic telangiectasia (HHT): Evaluation and therapy for specific vascular lesions
Hereditary hemorrhagic telangiectasia (HHT): Routine care including screening for asymptomatic AVMs
Nonselective NSAIDs: Overview of adverse effects
Psychogenic purpura (Gardner-Diamond syndrome)
Thrombotic and hemorrhagic disorders due to abnormal fibrinolysis
Acquired hemophilia A (and other acquired coagulation factor inhibitors)
Acquired von Willebrand syndrome
Acute treatment of bleeding and surgery in hemophilia A and B
Biology and normal function of factor VIII and factor IX
Bleeding disorder of unknown cause (BDUC)
Chronic complications and age-related comorbidities in people with hemophilia
Clinical manifestations and diagnosis of hemophilia
Clinical presentation and diagnosis of von Willebrand disease
Factor XI (eleven) deficiency
Gene therapy and other investigational approaches for hemophilia
Genetics of hemophilia A and B
Hemophilia A and B: Routine management including prophylaxis
Inhibitors in hemophilia: Mechanisms, prevalence, diagnosis, and eradication
Pathophysiology of von Willebrand disease
Patient perspective: von Willebrand disease
Rare inherited coagulation disorders
von Willebrand disease (VWD): Gynecologic and obstetric considerations
von Willebrand disease (VWD): Treatment of major bleeding and major surgery
von Willebrand disease (VWD): Treatment of minor bleeding, use of DDAVP, and routine preventive care
Biology and normal function of factor VIII and factor IX
Clinical use of coagulation tests
Overview of hemostasis
Plasminogen deficiency
Preoperative assessment of bleeding risk
Recombinant factor VIIa: Administration and adverse effects
The endothelium: A primer
Vitamin K-dependent clotting factors: Gamma carboxylation and functions of Gla
Antithrombin deficiency
Factor V Leiden and activated protein C resistance
Hereditary thrombophilia testing in adults without VTE
Inherited thrombophilias in pregnancy
Protein C deficiency
Protein S deficiency
Prothrombin G20210A
Diagnosis of immune TTP
Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA)
Drug-induced thrombotic microangiopathy (DITMA)
Evaluation and management of disseminated intravascular coagulation (DIC) in adults
HIV-associated cytopenias
Hereditary thrombotic thrombocytopenic purpura (hTTP)
Immune TTP: Initial treatment
Immune TTP: Management following recovery from an acute episode and during remission
Immune TTP: Treatment of clinical relapse
Pathophysiology of TTP and other primary thrombotic microangiopathies (TMAs)
Patient perspective: Thrombotic thrombocytopenic purpura (TTP)
Thrombotic microangiopathies (TMAs) with acute kidney injury (AKI) in adults: CM-TMA and ST-HUS
Thrombotic microangiopathy after kidney transplantation
Catheter-related upper extremity venous thrombosis in adults
Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity
Deep vein thrombosis in pregnancy: Clinical presentation and diagnosis
Evaluating adult patients with established venous thromboembolism for acquired and inherited risk factors
Overview of homocysteine
Overview of the causes of venous thrombosis
Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)
Prevention of venous thromboembolic disease in acutely ill hospitalized medical adults
Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients
Venous thromboembolism in pregnancy and postpartum: Treatment
Venous thromboembolism in pregnancy: Prevention
×
کتابخانه آنلاین و چاپی زبان اصلی
کتاب چاپی فارسی
ژورنال
ویديو آموزش
آپتودیت
کتابخانه آنلاین فارسی
Search
Do you want to add Medilib to your home screen?
Yes Please
No Thanks
Add Medilib to home screen